Biliary Tract Carcinoma
Oncology
2
Pipeline Programs
2
Companies
1
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
GS
Trial Timeline
Clinical trial activity over time
2024
2025
2026
2027
Gilead SciencesGemcitabine
Clinical Trials (1)
Total enrollment: 33 patients across 1 trials
Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)
Start: Mar 2024Est. completion: Jul 202733 patients
Phase 2Recruiting
Related Jobs in Oncology
Summer intern Neuroscience
Arvinas
New Haven - CT
18h ago
Medical Representative - CVRM - HCM
AstraZeneca
Vietnam - Ho Chi Minh City
23h ago
Operator
Sartorius Stedim Biotech
Shanghai
23h ago
Technician, Quality Assurance - Night Shift
Orca Bio
Sacramento, CA
23h ago
$65K - $71K/yr
Supervisor, Materials and Cold Chain Operations - Night Shift
Orca Bio
Sacramento, CA
Yesterday
$75K - $95K/yr
Supervisor, Materials and Cold Chain Operations - Day Shift
Orca Bio
Sacramento, CA
Yesterday
$75K - $95K/yr
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 33 patients
2 companies competing in this space